FUNCTIONAL PRECISION ONCOLOGY
Where science meets personalized cancer care.
Cure First is a nonprofit advancing functional precision oncology through the PARIS® Test, which uses living tumor cells to provide another source of information that may help inform treatment conversations.
Through the PARIS Test, we test living tumor cells against potential therapies and combine those results with molecular insights—providing information that goes beyond what DNA alone can tell us.
HOW CAN WE HELP
Find your path.
Whether you are navigating cancer treatment, caring for a patient, advancing research or supporting our mission, find the information most relevant to you.
Patients & Families
Understand the PARIS Test, how it works and whether it may be appropriate for you or someone you love.
EXPLORE PARIS >
Physicians
Learn how the PARIS Test works, explore the clinical science and evidence, and find resources to help you evaluate, discuss or refer to an appropriate patient for testing.
FOR PHYSICIANS >
Researchers & Collaborators
Explore the PARIS platform, our research and opportunities to advance functional precision oncology together.
EXPLORE OUR SCIENCE >
Support Our Mission
Help advance potentially transformational science, expand access to personalized cancer care and move promising discoveries closer to the patients who need them.
SUPPORT OUR MISSION >
THE PARIS TEST
Test your cancer cells outside your body.
Not Just the DNA.
Genomic testing can reveal alterations in a tumor’s DNA. The PARIS® Test adds functional information by testing living tumor cells against multiple therapies to observe how those cells respond.